ABC | Volume 111, Nº2, August 2018

Original Article Marino et al 123 I-MIBG Scintigraphy in Heart Failure Arq Bras Cardiol. 2018; 111(2):182-190 11. Bestetti RB, Coutinho-Netto J, Staibano L, Pinto LZ, Muccillo G, Oliveira JS. Peripheral and coronary sinus catecholamine levels in patients with severe congestiveheartfailureduetoChagas’disease.Cardiology.1995;86(3):202-6. 12. FlorasJS.Sympatheticnervoussystemactivationinhumanheartfailure:clinical implications of an updatedmodel. J AmColl Cardiol. 2009;54(5):375-85. 13. Carrio I, Cowie MR, Yamazaki J, Udelson J, Camici PG. Cardiac sympathetic imagingwithmIBGinheartfailure.JACCCardiovascImaging.2010;3(1):92-100. 14. Vasudevan NT, Mohan ML, Goswami SK, Prasad SV. Regulation of β -adrenergic receptor function: an emphasis on receptor resensitization. Cell Cycle. 2011;10(21):3684-91. 15. Ribeiro AL, Moraes RS, Ribeiro JP, Ferlin EL, Torres RM, Oliveira E, et al. Parasympathetic dysautonomia precedes left ventricular systolic dysfunction in Chagas disease. AmHeart J. 2001;141(2):260-5. 16. Gerbi FC, Takahashi JT, Cardinalli-Neto A, Nogueira PR, Bestetti RB. Heart rate variability in the frequency domain in chronic Chagas disease: Correlation of autonomic dysfunctionwith variables of daily clinical practice. Int J Cardiol.150(3):357-8. 17. Marin-Neto JA, Bromberg-Marin G, Pazin-Filho A, Simões MV, Maciel BC. Cardiac autonomic impairment and earlymyocardial damage involving the right ventricle are independent phenomena in Chagas’ disease. Int J Cardiol. 1998;65(3):261-9. 18. LandesmannMC,daFonsecaLM,deBPereiraB,doNascimentoEM,Rosado- de-Castro PH, de Souza SA, et al. Iodine-123 metaiodobenzylguanidine cardiac imaging as a method to detect early sympathetic neuronal dysfunction inchagasicpatientswithnormalorborderlineelectrocardiogram and preserved ventricular function. Clin Nucl Med. 2011;36(9):757-61. 19. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV. Pathogenesis of chronic Chagas heart disease. Circulation. 2007;115(9):1109-23. 20. Miranda CH, Figueiredo AB, Maciel BC, Marin-Neto JA, Simoes MV. Sustained ventricular tachycardia is associated with regional myocardial sympathetic denervation assessed with 123I-metaiodobenzylguanidine in chronic Chagas cardiomyopathy. J Nucl Med. 2011;52(4):504-10. 21. Gadioli LP, Miranda CH, Pintya AO, de Figueiredo AB, Schmidt A, Maciel BC, et al. The severity of ventricular arrhythmia correlates with the extent of myocardial sympathetic denervation, but not with myocardial fibrosis extent in chronic Chagas cardiomyopathy : Chagas disease, denervation and arrhythmia. J Nucl Cardiol. 2018;25(1):75-83. 22. RassiAJr,RassiA,RassiSG.Predictorsofmortality inchronicChagasdisease:a systematicreviewofobservationalstudies.Circulation.2007;115(9):1101-8. 23. Estorch M, Camprecios M, Flotats A, Mari C, Berna L, Catafau AM, et al. Sympathetic reinnervation of cardiac allografts evaluated by 123I-MIBG imaging. J Nucl Med. 1999;40(6):911-6. 24. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al; ADMIRE-HF Investigators. Myocardial iodine-123 meta- iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation inHeart Failure) study. J AmColl Cardiol. 2010;55(20):2212-21. 25. Nakata T, Nakajima K, Yamashina S, Yamada T, Momose M, Kasama S, et al. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. JACC Cardiovasc Imaging. 2013;6(7):772-84. 26. Ministério da Saúde. Secretaria de Vigilância emSaúde.BrazilianConsensus on Chagas Disease. Rev Soc Bras Med Trop. 2005;38 Suppl. 3:7-29. 27. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233-70. Erratum in: Eur Heart J Cardiovasc Imaging. 2016;17(4):412. Eur Heart J Cardiovasc Imaging. 2016;17 (9):969. 28. Morozumi T, Kusuoka H, Fukuchi K, Tani A, Uehara T, Matsuda S, et al. Myocardial iodine-123-metaiodobenzylguanidine images and autonomic nerve activity in normal subjects. J Nucl Med. 1997;38(1):49-52. 29. Patel AD, Iskandrian AE. MIBG imaging. J Nucl Cardiol. 2002;9(1):75-94. 30. Perkins A. Nuclear medicine: science and safety: London: John Libbey Company; 1995. 31. MontgomeryDC.DesignandAnalysisofExperiments.NewYork: JohnWiley & Sons; 1991. 32. Johnson RA, Bhattacharyya G. Statistics: principles andmethods: NewYork: John Wiley & Sons; 1987. 33. Ogita H, Shimonagata T, Fukunami M, Kumagai K, Yamada T, Asano Y, et al. Prognostic significance of cardiac (123)I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study. Heart. 2001;86(6):656-60. 34. Stefanelli A, Treglia G, Bruno I, Rufini V, Giordano A. Pharmacological interferencewith123I-metaiodobenzylguanidine:a limitationtodeveloping cardiac innervation imaging in clinical practice? Eur RevMed Pharmacol Sci. 2013;17(10):1326-33. 35. Machado FS, Jelicks LA, Kirchhoff LV, Shirani J, Nagajyothi F, Mukherjee S, et al. Chagas heart disease: report on recent developments. Cardiol Rev. 2012;20(2):53-65. 36. RassiA Jr,RassiA,LittleWC,XavierSS,RassiSG,RassiAG,etal.Development and validation of a risk score for predicting death in Chagas’ heart disease. N Engl J Med. 2006;355(8):799-808. 189